Adjuvant therapy for high-risk endometrial cancer

Giuseppe Damiano, Fabio Barra, Maria Laura Iaia, Giacomo Bregni, Simone Ferrero, Serafina Mammoliti

Research output: Chapter in Book/Report/Conference proceedingChapter


The majority of patients with endometrial cancer (EC) undergoes surgical management without receiving any adjuvant therapy. Based on clinical-pathological prognostic factors, EC risk classes have been distinguished in order to select patients with higher risk of relapse, as they can benefit from eventual post-surgical adjuvant treatments.

Original languageEnglish
Title of host publicationEndometrial Cancer
Subtitle of host publicationRisk Factors, Management and Prognosis
PublisherNova Science Publishers, Inc.
Number of pages20
ISBN (Electronic)9781536138887
ISBN (Print)9781536138870
Publication statusPublished - Jan 1 2018


  • Adjuvant therapy
  • Brachytherapy
  • Chemotherapy
  • External radiotherapy
  • High risk endometrial cancer

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Adjuvant therapy for high-risk endometrial cancer'. Together they form a unique fingerprint.

Cite this